Danaher Corporation (NYSE:DHR) Shares Sold by Bancreek Capital Management LP

Bancreek Capital Management LP cut its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 26.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,831 shares of the conglomerate's stock after selling 8,758 shares during the quarter. Danaher makes up about 7.3% of Bancreek Capital Management LP's investment portfolio, making the stock its 4th biggest position. Bancreek Capital Management LP's holdings in Danaher were worth $4,885,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. GHP Investment Advisors Inc. increased its holdings in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares during the last quarter. Heck Capital Advisors LLC bought a new stake in shares of Danaher in the fourth quarter worth about $27,000. Smallwood Wealth Investment Management LLC bought a new stake in shares of Danaher in the first quarter worth about $31,000. Rialto Wealth Management LLC bought a new stake in shares of Danaher in the fourth quarter worth about $34,000. Finally, Hurley Capital LLC bought a new stake in shares of Danaher in the fourth quarter worth about $34,000. 79.05% of the stock is owned by institutional investors.

Danaher Stock Up 0.3%

Shares of DHR traded up $0.64 during midday trading on Thursday, hitting $203.14. 852,456 shares of the company's stock traded hands, compared to its average volume of 3,493,330. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $281.70. The firm's fifty day moving average is $195.39 and its 200-day moving average is $207.80. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $145.38 billion, a price-to-earnings ratio of 39.48, a price-to-earnings-growth ratio of 2.82 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The firm had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. As a group, sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.63%. Danaher's dividend payout ratio is currently 24.85%.

Insider Activity

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president directly owned 15,179 shares of the company's stock, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the sale, the chairman directly owned 3,105,808 shares in the company, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

DHR has been the topic of several analyst reports. Wells Fargo & Company reduced their price objective on Danaher from $240.00 to $210.00 and set an "equal weight" rating on the stock in a research note on Wednesday, April 23rd. JPMorgan Chase & Co. lowered their price target on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. Stifel Nicolaus upgraded Danaher from a "hold" rating to a "buy" rating and set a $260.00 price target for the company in a report on Friday, March 14th. Citigroup reiterated a "buy" rating on shares of Danaher in a report on Monday, April 7th. Finally, Jefferies Financial Group lowered their price target on Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a report on Tuesday, April 22nd. Four investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $248.61.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.